EUVIMEDEUVIMED entdecken
Crossref

A polysaccharide from Pueraria lobata ameliorates hepatic fibrosis via gut microbiota-dependent suppression of ferroptosis

Jiangping Wu, Zhu Yang, Lingzhi Chen, Qiangbao Xu, Yingying Zhang, Yiping Yang, Mabhena Beloved, Sumiao Zhan, Wen Cao, Zihan Li, Guodong Wang, Qiuyue Lv und 1 weitere

Phytomedicine · 2026

DOI: 10.1016/j.phymed.2026.158123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Jiangping Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM, Anhui Provincial Engineering Laboratory for Screening and Re-eva…. Hauptthemen laut MEDLINE: Pueraria, Gastrointestinal Microbiome, Polysaccharides, Liver Cirrhosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Anhui University of Chinese Medicine, Studio.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hepatic fibrosis, driven by oxidative stress and subsequent hepatocellular injury, represents a major worldwide health challenge. Pueraria lobata Radix, a traditional Chinese herb, contains polysaccharides with demonstrated hepatoprotective properties, though their mechanisms remain incompletely defined. PURPOSE: This study aims to characterize the structure of P. lobata polysaccharide (PLP2) and to decipher its protective mechanisms against hepatic fibrosis. METHODS: PLP2, a homogeneous, water-soluble polysaccharide, was purified from P. lobata and structurally characterized. Subsequently, the hepatoprotective activity of PLP2 was investigated in a CCl₄-induced murine model of hepatic fibrosis. RESULTS: Structural analysis indicated that PLP2 (Mw = 142.9 kDa) was mainly composed of (1→4)-α-D-Glc and (1→4)-α-D-GalA units, with a minor presence of →4,6)-α-D-Glc-(1→ residues. In a CCl₄-induced murine model of hepatic fibrosis, PLP2 treatment effectively ameliorated liver injury, histopathological damage, and inflammatory responses. Mechanistically, PLP2 treatment restored mitochondrial ultrastructure and hepatic ATP levels, thereby suppressing hepatic ferroptosis through the activation of the Nrf2/HO-1/GPX4 axis. The indispensable role of Nrf2 was further validated using the inhibitor ML385, which abolished PLP2's protection. Notably, the hepatoprotective effects of PLP2 were predominantly dependent on gut microbiota integrity, as direct PLP2 treatment failed to protect hepatocytes in vitro. This role was further confirmed by the abolition of protection with antibiotic treatment and the transfer of benefits via fecal microbiota transplantation. CONCLUSION: These findings provide evidence that PLP2 exerts its anti-fibrotic effects through the gut microbiota-dependent suppression of ferroptosis via the Nrf2/HO-1/GPX4 axis, providing a solid scientific foundation for the clinical application of P. lobata.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PuerariaGastrointestinal MicrobiomePolysaccharidesLiver CirrhosisFerroptosisAnimalsMiceMaleCarbon TetrachlorideOxidative StressLiverMice, Inbred C57BLDrugs, Chinese Herbal

Stichwörter der Autor:innen

Gut-liver axisHepatic fibrosisOxidative stressPueraria lobata polysaccharidesStructural characterization

Substanzen

PolysaccharidesCarbon TetrachlorideDrugs, Chinese Herbal

Autor:innen und Institutionen

  • Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM, Anhui Provincial Engineering Laboratory for Screening and Re-evaluation of Active Compounds of Herbal Medicines in Southern Anhui, Anh…

Förderung

  • National Natural Science Foundation of China
  • Anhui University of Chinese Medicine
  • Studio
  • Anhui Provincial Department of Education
  • Natural Science Foundation of Anhui Province

Zitieren

APA

Wu, J., Yang, Z., Chen, L., Xu, Q., Zhang, Y., Yang, Y., Beloved, M., Zhan, S., Cao, W., Li, Z., Wang, G., Lv, Q., & Han, J. (2026). A polysaccharide from Pueraria lobata ameliorates hepatic fibrosis via gut microbiota-dependent suppression of ferroptosis. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.158123

Vancouver

Wu J, Yang Z, Chen L, Xu Q, Zhang Y, Yang Y, et al. A polysaccharide from Pueraria lobata ameliorates hepatic fibrosis via gut microbiota-dependent suppression of ferroptosis. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.158123

BibTeX
@article{Wu2026,
  author = {Wu, Jiangping and Yang, Zhu and Chen, Lingzhi and Xu, Qiangbao and Zhang, Yingying and Yang, Yiping and Beloved, Mabhena and Zhan, Sumiao and Cao, Wen and Li, Zihan and Wang, Guodong and Lv, Qiuyue and Han, Jun},
  title = {A polysaccharide from Pueraria lobata ameliorates hepatic fibrosis via gut microbiota-dependent suppression of ferroptosis},
  journal = {Phytomedicine},
  year = {2026},
  doi = {10.1016/j.phymed.2026.158123}
}
Kostenlos starten →